Status:
RECRUITING
Ultrafast Whole Genome Sequencing for Childhood Cancer
Lead Sponsor:
University of Cambridge
Collaborating Sponsors:
Illumina, Inc.
Cambridge University Hospitals NHS Foundation Trust
Conditions:
Cancer Childhood
Eligibility:
All Genders
Up to 24 years
Brief Summary
Cambridge University Hospitals NHS Foundation Trust (CUHNFT) is the Principal Treatment Centre for the East of England region, responsible for 120-150 patients \<16 years with a new diagnosis of paedi...
Eligibility Criteria
Inclusion
- Have given written informed consent to participate
- Be aged \<25 years of age
- Have confirmed or suspected malignancy
- For pilot/feasibility study (first 10 patients), only haematological malignancies (ALL/AML) will be included
- Have tumour and germline sample available - retrospectively collected or for prospective collection
Exclusion
- Inability to provide written informed consent (self or parent/guardian)
- Insufficient tissue (BM/PB/tissue) available for research purposes after collection for routine diagnostic purposes
Key Trial Info
Start Date :
October 19 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 17 2028
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07201038
Start Date
October 19 2022
End Date
October 17 2028
Last Update
October 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Addenbrookes Hospital
Cambridge, United Kingdom